clarithromycin 250 MG in 5 mL Oral Suspension
- RxCUI
- 309322
- RxNorm name
- clarithromycin 250 MG in 5 mL Oral Suspension
- Display name
- clarithromycin 250 MG in 5 mL Oral Suspension
- Full name
- clarithromycin 250 MG in 5 mL Oral Suspension
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:29
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Clarithromycin | CLARITHROMYCIN | A-S Medication Solutions | fad1e5a3-59f9-4868-9937-d3b061ab8f00 | 2026-02-19 | Warnings, Adverse reactions | 309322 |
| Clarithromycin | CLARITHROMYCIN | Sandoz Inc | 22457862-0f88-4be8-b507-1c8f264269f2 | 2023-09-13 | Warnings, Adverse reactions | 309322 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| fad1e5a3-59f9-4868-9937-d3b061ab8f00 | clarithromycin 250 MG in 5 mL Oral Suspension [PSN] · clarithromycin 50 MG/ML Oral Suspension [SCD] · clarithromycin 250 MG per 5 ML Oral Suspension [SY] | 3 | 19 | These highlights do not include all the information needed to use CLARITHROMYCIN FOR ORAL SUSPENSION safely and effectively. See full prescribing information for CLARITHROMYCIN FOR ORAL SUSPENSION. CLARITHROMYCIN for oral suspension, for oral use Initial U.S. Approval: 1991 | 20260219 |
| 22457862-0f88-4be8-b507-1c8f264269f2 | clarithromycin 250 MG in 5 mL Oral Suspension [PSN] · clarithromycin 50 MG/ML Oral Suspension [SCD] · clarithromycin 250 MG per 5 ML Oral Suspension [SY] | 3 | 15 | These highlights do not include all the information needed to use CLARITHROMYCIN FOR ORAL SUSPENSION safely and effectively. See full prescribing information for CLARITHROMYCIN FOR ORAL SUSPENSION. CLARITHROMYCIN for oral suspension, for oral use Initial U.S. Approval: 1991 | 20230913 |
| 903939b3-a01d-4593-85ca-cfe8d4d48d3e | clarithromycin 250 MG in 5 mL Oral Suspension [PSN] · clarithromycin 50 MG/ML Oral Suspension [SCD] · clarithromycin 250 MG per 5 ML Oral Suspension [SY] | 3 | 7 | Clarithromycin for Oral Suspension, USP | 20140411 |
| 94c182ed-f2d6-4f7f-bdd9-69b136c54623 | clarithromycin 250 MG in 5 mL Oral Suspension [PSN] · clarithromycin 50 MG/ML Oral Suspension [SCD] · clarithromycin 250 MG per 5 ML Oral Suspension [SY] | 3 | 4 | CLARITHROMYCIN TABLETS, USP AND CLARITHROMYCIN FOR ORAL SUSPENSION, USP Rx only | 20131024 |
| 2e899f4a-a2e9-445c-a0ed-6ad811e997e6 | clarithromycin 250 MG in 5 mL Oral Suspension [PSN] · clarithromycin 50 MG/ML Oral Suspension [SCD] · clarithromycin 250 MG per 5 ML Oral Suspension [SY] | 3 | 1 | BIAXIN® Filmtab® (clarithromycin tablets, USP) BIAXIN® XL Filmtab® (clarithromycin extended-release tablets) BIAXIN® Granules (clarithromycin for oral suspension, USP) | 20120222 |